Skip to content

the clinical study on intervention of delayed CINV by fine-tuning external application acupoint application

the clinical study on intervention of delayed CINV by fine-tuning external application acupoint application

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005518
Enrollment
Unknown
Registered
2022-01-10
Start date
2022-01-05
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy induced nausea and vomiting

Interventions

Sponsors

Wuxi Hospital Affiliated to Nanjing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Age >18; ? Clearly diagnosed as malignant tumor patients; ? Patients receiving chemotherapy with platinum; ? Had received =1 course of chemotherapy before enrollment, and planned to receive =2 courses of chemotherapy; (5) Normal language expression ability, have the ability to judge their own situation; ? Good compliance and informed consent should be signed.

Exclusion criteria

Exclusion criteria: ? Mechanical obstruction confirmed by gastroscopy or gastrointestinal angiography; ? Have other diseases that may cause nausea and vomiting, such as brain metastasis and hypothyroidism; ? Unable to determine curative effect due to incomplete data; ? Patients with intellectual or mental disorders.? Good compliance and informed consent should be signed.

Design outcomes

Primary

MeasureTime frame
nausea;vomiting;

Countries

China

Contacts

Public ContactXIAODAN ZHU
pwtyz@126.com13665187186

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026